RadSense

Radial Artery Hemostasis Device

Health Tech & Life Sciences
Non Active, May 2022 ceased to operate
Pre-Funding Caesarea, Israel Founded 2016
Last updated 2026-06-18
Total raised
Stage
Pre-Funding
Founded
2016
Headcount
1-10
HQ
Caesarea, Israel
Sector
Health Tech & Life Sciences

About

RadSense is developing a device for applying pressure to the radial artery in order to prevent bleeding while still allowing blood flow through the radial artery.

Q&A

What is RadSense's primary focus?
RadSense is developing a device for applying pressure to the radial artery to prevent bleeding while allowing blood flow.
When was RadSense founded?
RadSense was founded in May 2016.
What is the current status of RadSense?
RadSense is currently inactive and ceased to operate in May 2022.
Where is RadSense headquartered?
RadSense is headquartered in Caesarea, Israel.
What sector does RadSense operate in?
RadSense operates in the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Medical Treatment & Therapeutics.
Does RadSense hold any patents?
Yes, RadSense holds one patent.
What is the product stage of RadSense's device?
RadSense's product is in the clinical trial stage.

Team · 2

Founder · Founder
LinkedIn ↗
Founder · Founder
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Highlights

1 Patents

Tags

medical-devicessurgeonssurgerycardiovascular
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

Identifiers & details

Founded2016-5
Status reasonNon Active, May 2022 ceased to operate